Positive Results

Our Results Are Different

In 19 years, we have raised over $9 million, including $742,467 so far in 2019, to help find a cure for cancer. All proceeds benefit Basic Science Cancer Research, supporting the early, novel ideas that then lead to additional grants. The money we have raised has resulted in over $66 million in additional research funding.

The H Foundation Cancer Therapeutics Pipeline

In partnership with the Basic Science Research Division of the Robert H. Lurie Comprehensive Cancer Center, our funding has established The H Foundation Cancer Therapeutics Pipeline, seeding the discovery of new cancer drugs and early stage diagnostics. There are currently 25 compounds in the pipeline, targeting a number of cancers. We are proud to announce three of the compounds are moving into FDA sanctioned clinical trials for leukemia, lymphoma, pancreatic, and other cancers. Together, we are getting closer to finding a cure!

Oncofertility Consortium

One of the most exciting successes of the Cancer Center’s basic science research is in the area of emerging science of Oncofertillity. This new research will create an interdisciplinary team of biomedical and social scientists, oncologists, pediatricians, social works and medical ethicists to help women preserve their fertility while being treated for cancer.

Go to The H Foundation to learn more about the basic science cancer research we fund.

Posted July 30, 2019 at 9:06 AM

Join Us In the Fight Against Cancer

How you can help

May 26, 2023
Terry Bradshaw Named 2023 Goombay Bash Guest of Honor
The H Foundation & The Annual Goombay Bash Celebrates 21 Years Fueling Cancer Research!We're very excited to announce this year's Goombay Bash Celebrity Guest of Honor, Terry Bradshaw!For more than two decades, The H Foundation has donated crucial funding to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.… Read More
  • Follow us on Facebook
  • Follow us on Twitter
  • Follow H Foundation on YouTube
  • Connect with H Foundation on LinkedIn
  • Read our blog